French Hypertrophic Cardiomyopathy Observatory
Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood disease with an assumption insufficiently codified. There is no data available in France on the profile of patients, diagnostic methods and assessment and therapeutic use. The purpose of this study is to establish a monitoring of
| Condition(s) | Hypertrophic Cardiomyopathy |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Hypertrophic cardiomyopathy (Hypertrophic CardioMyopathy=HCM) remains a poorly understood disease with an assumption insufficiently codified. There is no data available in France on the profile of patients, diagnostic methods and assessment and therapeutic use. The purpose of this study is to establish a monitoring of patients with HCM (sarcomere of origin or not) in France (diagnosis, treatment) |
| Who can participate | Inclusion Criteria: * Age ≥ 15 years old * Patient with HCM defined by an ultrasound thickness of the left ventricle ≥ 13 mm if familial or ≥ 15 mm if sporadic Exclusion Criteria: * Expressed refusal to participate in the study * Significant aortic stenosis (\<1 cm ²) |
| Ages | 15 Years |
| Sex | All |
| Lead sponsor | French Cardiology Society |
| Locations | Paris, France |
| Start date | 2010-01 |
| NCT ID | NCT01091480 |
| Official listing | https://clinicaltrials.gov/study/NCT01091480 |